Financial Incentives for Living Kidney Donors
Trial Summary
What is the purpose of this trial?
This study evaluates whether using small financial incentives increases patient compliance with nationally-mandated living kidney donor follow-up at 6-months, 1-year, and 2-years after donation. Half of participants will receive a financial incentive (mailed gift card) after completing required follow-up activities (brief questionnaire and lab draw), while the other half will be asked to complete the required follow-up activities but will not receive a financial incentive (current standard of care).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Financial Incentive, Monetary Incentive, Financial Reward, Economic Motivation for living kidney donors?
Research shows that financial incentives can improve healthcare performance by motivating providers to achieve better results, as seen in programs for chronic kidney disease and other conditions. These incentives help overcome financial barriers and align rewards with desired outcomes, suggesting they could also encourage more people to become living kidney donors.12345
Is it safe for living kidney donors to receive financial incentives?
The research suggests that living kidney donation is generally safe, but donors may face risks like increased chances of chronic diseases and psychosocial issues. Financial incentives are being studied to improve follow-up care, but safeguards are needed to prevent coercion and ensure donor safety.678910
How do financial incentives for living kidney donors differ from other treatments for kidney donation?
Financial incentives for living kidney donors are unique because they offer monetary rewards to encourage individuals to donate a kidney, unlike traditional approaches that rely solely on altruism. This method is similar to financial incentives used in other health behaviors, like promoting physical activity, but it specifically targets increasing the number of kidney donations.1112131415
Research Team
Daniel Warren, PhD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for adults over 18 who have donated a kidney at Johns Hopkins or University of Maryland Medical Centers, speak English, and live in the U.S. It's not for those who don't speak English or international donors.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Follow-up
Participants complete follow-up activities at 6-months, 1-year, and 2-years post-donation, including a brief questionnaire and lab draw
Incentive Evaluation
Evaluation of the effectiveness of financial incentives on compliance with follow-up activities
Treatment Details
Interventions
- Financial Incentive
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
University of Maryland, Baltimore
Collaborator
The Living Legacy Foundation
Collaborator
University of Maryland School of Medicine
Collaborator